• Lutte contre les cancers

  • Approches psycho-sociales

  • Autres organes

Hospital admission for neurologic disorders among five-year survivors of non-central nervous system tumors in childhood: a cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

Menée au Danemark, en Islande, en Finlande et en Suède à partir de données portant sur 151 118 témoins et sur 15 967 patients ayant survécu 5 ans à un cancer du système nerveux périphérique diagnostiqué pendant l'enfance, cette étude analyse les facteurs liés au risque de troubles neurologiques et les hospitalisations associées (755 patients présentant des troubles)

Large, comprehensive studies of the risk for neurologic disorders among long-term survivors of non-central nervous system (CNS) childhood cancers are lacking. Thus, the aim of this study was to assess the lifetime risk of Nordic non-CNS childhood cancer survivors for neurologic disorders. We identified 15,967 five-year survivors of non-CNS childhood cancer diagnosed in Denmark, Iceland, Finland, and Sweden in 1943–2008, and 151,118 matched population comparison subjects. In-patient discharge diagnoses of neurologic disorders were used to calculate relative risks (RRs) and absolute excess risks (AERs). A neurologic disorder was diagnosed in 755 of the survivors while 370 were expected, yielding a RR of 2.0 (95% confidence interval (CI) 1.9−2.2). The highest risks were found among survivors of neuroblastoma (4.1; 95% CI 3.2−5.3) and leukemia (2.8; 95% CI 2.4−3.2). The AER decreased from 331 (278−383) excess neurologic disorders per 100,000 person-years 5–9 years after diagnosis to 82 (46−118) ≥ 20 years after diagnosis. Epilepsy was the most common diagnosis (n=229, 1.4% of all survivors), and significantly increased risks were seen among survivors of eight out of 12 types of childhood cancer. Survivors of neuroblastoma had remarkably high risks (RR ≥ 10) for hospitalization for paralytic syndromes and hydrocephalus, while survivors of leukemia had additional high risks for dementia, encephalopathy, and neuropathy. In conclusion, survivors of non-CNS childhood cancer are at high risk for neurologic disorders, especially within the first decade after diagnosis. Therefore, intensive follow-up to identify those who require close management is needed. This article is protected by copyright. All rights reserved.

International Journal of Cancer 2019

Voir le bulletin